CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
学术性即时抗 CD19 CAR-T 细胞治疗在多难治性免疫性血小板减少症患者中诱导持久缓解及短暂性阵发性睡眠性血红蛋白尿型细胞扩增
英文原题：Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopenia.
查看英文原题
Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopenia.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
暂无。
展开英文摘要原文
Not available.
论文信息
- 作者
- Plümer KA、Hörster K、Teichert M、Reinhardt HC、Tzalavras A、Röth A、Von Tresckow B
- 第一作者单位
- Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen.Germany
- 通讯作者单位
- Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen. bastian.vontresckow@uk-essen.de.Germany
- 期刊
- Haematologica2026 Jun 25
- 原文标识
- PubMed 42345064 · DOI 10.3324/haematol.2026.300887